Reviewing Grab (NASDAQ:GRAB) & Lifeward (NASDAQ:LFWD)

Lifeward (NASDAQ:LFWD) and Grab (NASDAQ:GRAB) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Analyst Recommendations

This is a summary of current ratings and price targets for Lifeward and Grab, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1	0	3	0	2.50
Grab	0	4	5	0	2.56

Lifeward currently has a consensus price target of $6.17, indicating a potential upside of 945.20%. Grab has a consensus price target of $6.37, indicating a potential upside of 16.91%. Given Lifeward’s higher probable upside, research analysts clearly believe Lifeward is more favorable than Grab.

Insider & Institutional Ownership

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 55.5% of Grab shares are owned by institutional investors. 2.7% of Lifeward shares are owned by insiders. Comparatively, 3.6% of Grab shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Lifeward and Grab”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$25.66 million	0.41	-$28.94 million	($2.97)	-0.20
Grab	$2.80 billion	7.85	-$105.00 million	$0.04	136.25

Lifeward has higher earnings, but lower revenue than Grab. Lifeward is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Lifeward has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Grab has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500.

Profitability

This table compares Lifeward and Grab’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lifeward	-121.82%	-183.18%	-109.28%
Grab	3.81%	1.91%	1.19%

Summary

Grab beats Lifeward on 12 of the 14 factors compared between the two stocks.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

About Grab

Grab Holdings Limited engages in the provision of superapps in Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam. The company offers its Grab ecosystem, a single platform with superapps for driver- and merchant-partners and consumers, that allows access to mobility, delivery, digital financial services, and enterprise sector offerings. Grab Holdings Limited is headquartered in Singapore.